VU0359595

VU0359595
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
Cay10955-1 1 mg -

6 - 10 Werktage*

55,00 €
Cay10955-5 5 mg -

6 - 10 Werktage*

191,00 €
Cay10955-10 10 mg -

6 - 10 Werktage*

323,00 €
Cay10955-25 25 mg -

6 - 10 Werktage*

741,00 €
 
Phospholipase D (PLD) is an enzyme that cleaves the head group from phospholipids, producing the... mehr
Produktinformationen "VU0359595"
Phospholipase D (PLD) is an enzyme that cleaves the head group from phospholipids, producing the second messenger phosphatidic acid. Two mammalian isoforms of PLD, PLD1, and PLD2, have been identified, with multiple splice variants of each. Although the two isoforms share structural and functional features, they are regulated differently and apparently subserve distinct roles. VU0359595 is an inhibitor of PLD1 (IC50 = 3.7 nM) that is >1,700-fold selective over PLD2 (IC50 = 6.4 µM). Preliminary evidence suggests that VU0359595 does not interact with the catalytic site of PLD, but instead may bind and inhibit PLD through an allosteric site.Formal Name: (1R,2R)-N-[(1S)-2-[4-(5-bromo-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-phenyl-cyclopropanecarboxamide, (1S,2S)-N-[(1S)-2-[4-(5-bromo-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-phenyl-cyclopropanecarboxamide. Synonyms: CID-53361951, ML-270. Molecular Formula: C25H29BrN4O2. Formula Weight: 497.4. Purity: >95% (mixture of diastereomers). Formulation: (Request formulation change), A crystalline solid. Solubility: DMSO: 5 mg/ml. lambdamax: 293 nm. SMILES: C[C@@H](CN1CCC(CC1)N2C(NC3=C2C=CC(Br)=C3)=O)NC([C@@H]4C[C@H]4C5=CC=CC=C5)=O.C[C@@H](CN6CCC(CC6)N7C(NC8=C7C=CC(Br)=C8)=O)NC([C@H]9C[C@@H]9C%10=CC=CC=C%10)=O. InChi Code: InChI=1S/2C25H29BrN4O2/c2*1-16(27-24(31)21-14-20(21)17-5-3-2-4-6-17)15-29-11-9-19(10-12-29)30-23-8-7-18(26)13-22(23)28-25(30)32/h2*2-8,13,16,19-21H,9-12,14-15H2,1H3,(H,27,31)(H,28,32)/t16-,20+,21-,16-,20-,21+/m00/s1. InChi Key: ZJJZIOCVJFWBFM-QDZXWRQZSA-N.
Schlagworte: CID-53361951, ML-270, (1R,2R)-N-[(1S)-2-[4-(5-bromo-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]-2-phenyl-cyclopropanecarboxamide, (1S,2S)-N-[(1S)-2-[4-(5-bromo-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl]
Hersteller: Cayman Chemical
Hersteller-Nr: 10955

Eigenschaften

Anwendung: PLD1 inhibitor
MW: 497.4 D
Formel: C25H29BrN4O2
Reinheit: >95% (mixture of diastereomers)
Format: Crystalline Solid

Datenbank Information

KEGG ID : K01115 | Passende Produkte

Handhabung & Sicherheit

Lagerung: -20°C
Versand: +20°C (International: -20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "VU0359595"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen